Life Extension Magazine November 2008
Preventing Cardiovascular Disease Naturally
By Julius Goepp, MD
In our war against heart disease,1 too many Americans sadly continue to rely purely on risky surgical treatments that can only be effective after the fact—after years of neglect and even abuse of their naturally resilient bodies.2-6 And while our pharmacopoeia of drugs is indeed large and powerful, it is only a small part of an integrated solution to this global problem.7-9
The good news is that experts are now increasingly recognizing the value of nutritional, dietary, and lifestyle therapies for cardiovascular disease prevention and management.1 In particular, an apparently simple combination of nutrients (from a berry and vegetable sprouts) has shown remarkable clinical effectiveness in lowering dangerous low-density lipoprotein (LDL) and triglycerides, raising protective high-density lipoprotein (HDL), reducing inflammation, and reversing visible atherosclerotic changes in damaged blood vessels. This unique formulation offers a broad-spectrum nutritional approach to preventing and treating arterial occlusion as we age.
A Powerful Nutritional Strategy Targeting Oxidation and Inflammation
Basic research has provided essential clues, which, coupled with ancient traditional healing wisdom, has resulted in a practical combination of nutrients for cardiovascular disease prevention. Let’s examine the elements of this simple cocktail in order to understand how the extract of an exotic berry, coupled with components found in vegetable sprouts, can address the inflammation and oxidant damage to our blood vessels.
Amla Berry Extract Optimizes Lipid Profiles, Blocks Atherosclerotic Changes
The Indian Gooseberry (Emblica officinalis) has been well known to practitioners of Ayurvedic medicine for more than 3,000 years.10 Long ignored by Western scientists in their quest for single “miracle molecules,” the Indian Gooseberry, also known as amla, belongs to a group of herbal preparations that according to Ayurvedic texts promote longevity, induce nourishment, and prevent the effects of age.11 Modern scientific research has found that the powers of many such herbal preparations stem from their potent antioxidant capabilities.10,12,13 There is growing evidence that the humble amla berry offers nearly legendary powers in healing and preventing atherosclerosis and related cardiovascular disease. In fact, it turns out that properly purified extracts of amla act in the following very precise ways to break the cycle of oxidation, inflammation, and plaque formation that underlies atherosclerosis and its disastrous consequences:
All of these laboratory studies explain how amla extracts achieve the effects long recognized by practitioners of ancient medicine. But where is the human clinical evidence to satisfy today’s critical Western scientists? As usual, human trials have lagged behind promising animal studies, but they are now catching up with compelling results. Here are just a few of the highlights of how amla is winning the hearts and minds of modern evidence-based medical providers.
Nutritionists in New Delhi provided amla supplements for 28 days to men aged 35-55 years, who had either normal or elevated cholesterol levels.33 Both groups experienced decreases in total cholesterol levels, which rose back to nearly their original levels two weeks after stopping the supplement.
A more detailed study comes from the All India Institute of Medical Sciences in New Delhi.34 These researchers used amla in the form of an amla-containing-vitamin C-rich traditional Indian supplement. Ten healthy young men took either the amla/vitamin C supplement or vitamin C alone daily for eight weeks, then no supplement for another eight weeks. Lipid profiles and glucose tolerance tests were done before supplementation and throughout the study. The results were remarkable: compared with the vitamin C-only group after eight weeks, the amla-supplemented group experienced a nearly 11% increase in HDL levels, more than a 16% drop in LDL levels, and a drop in the LDL-to-HDL ratio of more than 33%.34 These numbers are actually equal to or better than similar measurements in a recent study of the fibrate class of prescription drugs, in which significant safety concerns were raised!35 Subjects in the supplemented group also experienced a reduction of nearly 14% in fasting blood glucose and other measures of glucose tolerance—another beneficial effect for vascular health.34
Still more recent studies have been conducted but not yet published by the manufacturers of Amlamax™, a highly concentrated and purified form of the most active components of the amla berry. This extract is manufactured in strict adherence to the Ayurvedic principles of using a fresh fruit juice from a particular age of the berry, preserving the specific polyphenol content unique to amla.36 It is important to recognize that these studies have not yet been fully reviewed by a panel of experts (the “peer review” process), but the results are impressive and deserve mention.
Researchers enrolled normal healthy human volunteers who took the supplement for six months—either 500 mg/day (22 subjects), or 1,000 mg/day (17 subjects).36 Subjects’ average total cholesterol dropped from 215 mg/dL before supplementation to 185 mg/dL after three months, remaining below 190 mg/dL after six months of using the supplement. At the same time, cardioprotective HDL levels actually rose from 40 mg/dL before supplementation to just over 44 mg/dL by six months—a modest but statistically significant rise.
The same study demonstrated important effects of amla on other atherosclerosis risk factors as well. Levels of inflammatory C-reactive protein (CRP), which is associated with higher risk for atherosclerosis,12 dropped by 40% in the supplemented patients at six months.36 Finally, average blood sugar levels dropped from about 110 mg/dL (slightly elevated) to around 90 mg/dL (a level considered optimal by most doctors).36
Another unpublished study from Amlamax™ capitalizes on amla’s ability to mimic the actions of the statin drugs (preventing production of cholesterol in the body by blocking an enzyme in the production cascade).37 Fifteen patients were randomly assigned to receive the amla supplement 500 mg/day, while 15 others received only dietary restriction and exercise (the control group). No adverse effects were reported. Supplemented patients experienced a significant reduction in total cholesterol of 17%, in LDL of 21%, and a reduction in total triglycerides (non-cholesterol fats) of 24%. Significantly, this study also found a protective elevation of HDL—by a substantial 14% in the supplemented group.
Exciting data published in the Indian Journal of Pharmaceutical Sciences27 now show how amla (in the same concentrated form, Amlamax™), has an additional beneficial effect recently shown in statin drugs as well: relieving endothelial dysfunction and vascular stiffness directly.38 Researchers first induced disordered lipid profiles and atherosclerotic vascular changes in laboratory rabbits.27 When the diseased animals received amla extracts for four months, they experienced reversal of the blood vessel changes. In fact, the researchers reported that “the lumen [inside] of the aorta became normal as in the control group.” Measurement of the activity of a key enzyme in cholesterol synthesis showed it to be markedly inhibited (just as with “statin” drugs). The researchers concluded that amla exerts its powerful anti-atherosclerosis activity by a variety of factors, including its strong antioxidant capacity which prevents oxidation of LDL (and hence inflammation), and its inhibition of the vital cholesterol-producing enzyme.
These studies provide compelling modern scientific support for wisdom that’s already three millennia old: amla extracts, properly prepared and purified, affect virtually every phase in the cascade of events leading to atherosclerosis. Purified amla extracts can go head-to-head with existing pharmacological therapies in fighting cardiovascular diseases by lowering levels of dangerous LDL and raising those of protective HDL, inhibiting oxidant damage to endothelial cells and other tissues, reducing inflammatory changes that promote vascular damage, and now actually reversing significant visible atherosclerotic changes in damaged blood vessels.
HDL: What Makes it Beneficial?
Educated readers already know that HDL is considered a helpful form of blood lipid that is known to be cardioprotective—but even medical scientists are only now learning exactly why. There are two main reasons: HDL proteins hasten the reverse transport of cholesterol away from the arterial wall for elimination in the liver,39 and certain proteins in the HDL complex directly prevent the LDL oxidation that is an early trigger for atherosclerosis.40,41 For these reasons, pharmaceutical companies have been hot on the trail of drugs that not only lower LDL, but raise HDL levels—unfortunately with only mixed results.41,42
In addition to HDL-raising efforts, therefore, scientists are pursuing ways to build on the cardioprotective effect of HDL-associated protein complexes. Enhancing HDL’s ability to prevent LDL oxidation is one useful and effective approach. That is why we’re getting so excited about other proteins found in and around the HDL complex itself—proteins that are turning out to have a dramatic impact on cardioprotection and longevity.
One of the most promising avenues under exploration is modulation of paraoxonase 1 (PON1). Paraoxonase 1 is a serum enzyme capable of detoxifying toxic compounds used as insecticides into relatively harmless compounds,43-45 and it has now been found as part of the HDL protein complex, where it directly contributes to HDL’s antioxidant effects.40,41,46,47 Increased PON1 activity is associated with decreased risk of cardiovascular disease,48,49 while people with low PON1 levels are more likely to develop the metabolic syndrome and its deadly components.41 Promoting PON1 activity has become an important goal in the search for drug treatments to reduce cardiovascular risk.42
Another protein with a vital role in cholesterol management is cholesteryl ester transfer protein (CETP), which helps transfer cholesteryl esters from beneficial HDL to detrimental very low-density lipoprotein (VLDL) and LDL. Individuals who are deficient in CETP have elevated levels of protective HDL.50 This means that, in contrast to PON1, increased CETP activity is associated with increased cardiovascular risk, while inhibition of CETP may reduce risk and enhance health.50 In fact, recent evidence shows that partial suppression of CETP activity in human plasma decreases lipid transfer to the dangerous LDL complexes51—making CETP inhibition a promising area for drug development.50